This Article Full Text (OnlineFirst PDF) All Versions of this Article: 0269881107083998v1 23/1/106    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hung, G. C.-L. Articles by Chen, Y.-Y. Search for Related Content PubMed PubMed Citation Articles by Hung, G. C.-L. Articles by Chen, Y.-Y. Social Bookmarking                         What's this?

Combined low-dose clozapine with low-dose aripiprazole in a schizophrenic patient

¹ Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan.
² Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan and Institute of Public Health and Department of Social Medicine, National Yang Ming University, Taipei, Taiwan.

^* To whom correspondence should be addressed.

	Abstract

Aripiprazole, a partial dopaminergic agonist, represents a well-tolerated and effective addition to the antipsychotic armamentarium. However, accumulated data indicates that aripiprazole may still induce extrapyramidal side effects (EPS) in susceptible patients. Guidelines for treating schizophrenia have consistently recommended antipsychotic monotherapy. Nevertheless, in certain clinical situations, a thorough evaluation of the benefit/risk ratio suggests that combinations of antipsychotic agents may improve treatment efficacy and tolerability. We report a schizophrenic patient for whom sequential administration of aripiprazole and risperidone induced severe EPS, and subsequent combination therapy with of clozapine and aripiprazole achieved adequate symptom control and markedly reduced EPS.

Key Words: aripiprazole, extrapyramidal side effects, clozapine, polypharmacy

First published on February 28, 2008, doi:10.1177/0269881107083998

Journal of Psychopharmacology 2009;23:106.

A more recent version of this article appeared on January 1, 2009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?